Perspective Therapeutics (CATX) Accumulated Depreciation (2011 - 2026)
Perspective Therapeutics (CATX) posted Accumulated Depreciation of $7.3 million for Q1 2026, up 18.12% sequentially from $6.2 million in Q4 2025, and up 98.59% YoY from $3.7 million in Q1 2025.
Perspective Therapeutics (CATX) Accumulated Depreciation (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Accumulated Depreciation for 14 years, with the latest figure at $7.3 million in Q1 2026.
- Quarterly Accumulated Depreciation rose 98.59% year-over-year to $7.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.3 million (up 98.59% YoY) and the FY2025 annual result came in at $6.2 million, up 109.59% from the prior year.
- Accumulated Depreciation climbed to $7.3 million in Q1 2026 per CATX's latest filing, from $6.2 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $8.3 million in Q3 2023 and troughed at $15000.0 in Q4 2022.
- A 5-year average of $4.8 million and a median of $5.2 million in 2025 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation slumped 99.8% in 2022, then jumped 4360.0% in 2023.
- Over 5 years, Accumulated Depreciation stood at $15000.0 in 2022, then surged by 4360.0% to $669000.0 in 2023, then surged by 342.45% to $3.0 million in 2024, then jumped by 109.59% to $6.2 million in 2025, then gained by 18.12% to $7.3 million in 2026.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $7.3 million, $6.2 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 384.88 Mn | 384.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.47 Mn |
| Mar 31, 2026 | 7.33 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 5.20 Mn |
| Jun 30, 2025 | 4.42 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 669,000.00 |
| Sep 30, 2023 | 8.30 Mn |
| Jun 30, 2023 | 8.04 Mn |
| Mar 31, 2023 | 7.81 Mn |
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 7.56 Mn |
| Jun 30, 2022 | 7.50 Mn |
| Mar 31, 2022 | 7.43 Mn |
| Dec 31, 2021 | 7.37 Mn |
| Sep 30, 2021 | 7.31 Mn |